Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplastic Cells, Circulating 2Colorectal Neoplasms 2Neoplasms 1Neoplasm, Residual 1Colonic Neoplasms 1

Interventions

Blood Specimen Collection 4Reverse Transcriptase Polymerase Chain Reaction 3Flow Cytometry 3Surgical Procedures, Operative 2Propofol 2Pirinitramide 2Morphine 2Laparoscopy 2Folfox protocol 2Capecitabine 2Bevacizumab 2Aspirin 2lanreotide 1Trastuzumab 1Taxes 1Standard of Care 1Sorafenib 1Sevoflurane 1Radiotherapy 1Radiofrequency Ablation 1Oxaliplatin 1Octreotide 1Neoadjuvant Therapy 1Magnetic Resonance Imaging 1Leucovorin 1Injections, Epidural 1Hematologic Tests 1Gemcitabine 1Everolimus 1Ethiodized Oil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplastic Cells, Circulating × Pirinitramide × Gastrointestinal × Clear all
NCT03700411 2023-12-07

POACC-1

The Institute of Molecular and Translational Medicine, Czech Republic

Phase 4 Completed
125 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Colorectal Neoplasms

NCT03700541 2023-12-07

POACC-2

The Institute of Molecular and Translational Medicine, Czech Republic

Phase 4 Completed
71 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡